<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03452709</url>
  </required_header>
  <id_info>
    <org_study_id>ACTIVA</org_study_id>
    <nct_id>NCT03452709</nct_id>
  </id_info>
  <brief_title>Effectiveness of Non-pharmacological Interventions in Patients With Cardiovascular Risk Factors in Primary Care</brief_title>
  <official_title>Clinical Trial of the Effectiveness of Non-pharmacological Interventions (Physical Activity + ABPM) in Patients With Cardiovascular Risk Factors in Primary Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MurciaSalud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Consejeria de sanidad.Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal objective is analyzed whether a selective intervention no pharmacological (use
      of ABPM +/- prescription of physical exercise) for cardiovascular risk factors in patients
      with high cardiovascular risk in primary prevention is associated with a decrease in
      cardiovascular risk measured using the risk Score tables for countries with a low risk. It
      will be independently analized the effectiveness of systematic use of ABPM and the
      prescription of physical exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease continues to be the main cause of death in Western countries, with a
      very high prevalence (affecting &gt;1 in every 3 adult Americans), and contributes as one of the
      highest annual healthcare costs. There is still enormous potential for improving prevention
      although notable efforts have already been made. In the Spanish population, the following
      cardiovascular risk factors have been identified as being most prevalent: arterial
      hypertension, dyslipidemia, having a sedentary lifestyle, tobaccoism, obesity and diabetes.

      Essential Arterial Hypertension (EAH) is the most prevalent cardiovascular risk factor in the
      world and the main cause of cardiovascular disease. There are many clinical practice guides
      which recommend carrying out moderate physical activity to prevent, delay or reduce
      hypertension, given that the practice of community interventions with physical activity have
      been efficient.

      The indication to perform Itinerant Monitorization blood pressure in the diagnosis of
      hypertension is included in the latest draft of the clinical practice guideline from NICE,
      National Institute for Health and Clinical Excellence .

      Other cardiovascular risk factor to take into account is dyslipidemia, the prevalence of
      dyslipidemia is 16.2% in adults aged over 20 years. For this condition, physical activity is
      also recommended.

      When faced with a sedentary lifestyle or physical inactivity two intervention measures are
      available for reducing its incidence: verbal healthcare advice (taking advantage of the
      patients visit to the consultation) and the prescription of physical exercise.

      Taking into account the interventions mentioned that can be carried out in the face of risk
      factors, and that a multifactorial intervention is more efficient that individual
      interventions, the investigators have designed a clinical trial which attempts to improve
      most of the principal risk factors. The objective is to reduce the cardiovascular risk of
      patients using a multifactorial intervention on hypertension, dyslipidemia, sedentary
      lifestyle. The investigators will evaluate the efficiency of a program for official
      prescriptions for physical exercise compared to structured verbal advice in hypertense
      patients undergoing treatment and who have another risk factors (dyslipidemia being treated
      for more than one year or they are smokers), including action to improve the treatment
      adaptation for the hypertension (ABPM).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2011</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular risk .</measure>
    <time_frame>Every 3 months , up to 12 months.</time_frame>
    <description>Tables for countries with low cardiovascular risk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic arterial tension</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diastolic arterial tension</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol levels.</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>blood levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>International Physical Activity Questionniare (IPAQ) 600-3000 MET (METs are multiples of the resting metabolic rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacological treatment.</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>Number of antihypertensive and hypolipemiant drug and dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EUROFIT battery</measure>
    <time_frame>Every 3 months , up to 12 months</time_frame>
    <description>Score obtained</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">3656</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Control group: no intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Only the normal practise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>therapeutic exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group the intervention is the prescription of physical activity. The duration of the groups is planned to be from 12 weeks with 3 programmed sessions per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABPM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group the arterial pressure is evaluated with ABPM.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>therapeutic exercise + ABPM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>therapeutic exercise</intervention_name>
    <description>The duration of the groups is planned to be from 12 weeks with 3 programmed sessions per week. physical activity programmed by an instructor in patient with high risk of cardiovascular.</description>
    <arm_group_label>therapeutic exercise</arm_group_label>
    <arm_group_label>therapeutic exercise + ABPM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ABPM ambulatory blood pressure monitoring</intervention_name>
    <description>Arterial pressure is a biological variable which fluctuates over a 24 hour period depending on the period of activity/rest, which is known as circadian the BP rhythm. Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) vary, on average, more than 50 mm Hg throughout the day in a normotensive adult.</description>
    <arm_group_label>ABPM</arm_group_label>
    <arm_group_label>therapeutic exercise + ABPM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing treatment with at least one hypertense drug due to HTA and at least one
             hypolipemiant drug prescribed due to hypercholesterolemia, or other risk factor. The
             treatment should have a minimum duration time of 12 months prior to inclusion in the
             study.

          -  Patient in Primary Prevention.

          -  Finding oneself in the sedentary lifestyle category or through activation of the
             simplified active questionnaire of physical activity extracted from the Lipid Research
             Clinics prevalence Study

        Exclusion Criteria:

          -  Serious or terminal diseases.

          -  Diagnosis of ischemic and/or cerebrovascular cardiopathy.

          -  Patients with a limiting pathology which prevents physical exercise being performed.

          -  Serious mental illnesses: Psychosis, Major depressive disorder, Neurosis.

          -  Diabetes mellitus.

          -  Patients with limiting pathology preventing them from carrying out physical exercise.

          -  Serious mental diseases: Psychosis, Major depresive disorder, Neurosis.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A LOPEZ-SANTIAGO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consejeria de sanidad y consumo, Direccion general de planificacion, ordenacion sanitaria y farmaceutica e investigacion.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fundación para la Formación e Investigación Sanitarias de la Región de Murcia</name>
      <address>
        <city>Murcia</city>
        <state>Comunidad Autonoma De La Region De Murcia</state>
        <zip>30003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh/68002318</url>
    <description>MeSH</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh?term=PRIMARY%20PREVENTION</url>
    <description>MeSH</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh?term=physical%20activity</url>
    <description>MeSH</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/mesh/68018660</url>
    <description>MeSH</description>
  </link>
  <reference>
    <citation>Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15. Erratum in: Circulation. 2011 Oct 18;124(16):e426. Circulation. 2011 Feb 15;123(6):e240.</citation>
    <PMID>21160056</PMID>
  </reference>
  <reference>
    <citation>Medrano MJ, Cerrato E, Boix R, Delgado-Rodríguez M. [Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies]. Med Clin (Barc). 2005 Apr 30;124(16):606-12. Spanish.</citation>
    <PMID>15871776</PMID>
  </reference>
  <reference>
    <citation>Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 Feb;16(2):434-44.</citation>
    <PMID>8432214</PMID>
  </reference>
  <reference>
    <citation>Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002 Nov 2;360(9343):1347-60. Review.</citation>
    <PMID>12423980</PMID>
  </reference>
  <reference>
    <citation>Martín-Baranera M, Campo C, Coca A, de la Figuera M, Marín R, Ruilope LM; en representación del Grupo de Investigadores DICOPRESS. [Stratification and degree of control of cardiovascular risk factors in hypertensive Spanish population. Results of the DICOPRESS study]. Med Clin (Barc). 2007 Jul 14;129(7):247-51. Spanish.</citation>
    <PMID>17683705</PMID>
  </reference>
  <reference>
    <citation>Sierra C, De la Sierra A, Sobrino J, Segura J, Banegas JR, Gorostidi M, Ruilope LM; en representación de los Investigadores del Registro Nacional de MAPA. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). [Ambulatory blood pressure monitoring (CABPM): clinical characteristics of 31,530 patients]. Med Clin (Barc). 2007 Jun 2;129(1):1-5. Spanish.</citation>
    <PMID>17570178</PMID>
  </reference>
  <reference>
    <citation>Hypertension: clinical management of primary hypertension in adults NICE guideline. Draft for consultation, February 2011. access (29/3/2011: http://www.nice.org.uk/nicemedia/live/12167/53225/53225.pdf).</citation>
  </reference>
  <reference>
    <citation>Lee LL, Arthur A, Avis M. Evaluating a community-based walking intervention for hypertensive older people in Taiwan: a randomized controlled trial. Prev Med. 2007 Feb;44(2):160-6. Epub 2006 Oct 20.</citation>
    <PMID>17055561</PMID>
  </reference>
  <reference>
    <citation>Elley CR, Garrett S, Rose SB, O'Dea D, Lawton BA, Moyes SA, Dowell AC. Cost-effectiveness of exercise on prescription with telephone support among women in general practice over 2 years. Br J Sports Med. 2011 Dec;45(15):1223-9. doi: 10.1136/bjsm.2010.072439. Epub 2010 Nov 16.</citation>
    <PMID>21081641</PMID>
  </reference>
  <reference>
    <citation>Grandes G, Sanchez A, Sanchez-Pinilla RO, Torcal J, Montoya I, Lizarraga K, Serra J; PEPAF Group. Effectiveness of physical activity advice and prescription by physicians in routine primary care: a cluster randomized trial. Arch Intern Med. 2009 Apr 13;169(7):694-701. doi: 10.1001/archinternmed.2009.23.</citation>
    <PMID>19364999</PMID>
  </reference>
  <reference>
    <citation>Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002 Apr 2;136(7):493-503.</citation>
    <PMID>11926784</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2011</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Disease;</keyword>
  <keyword>primary prevention;</keyword>
  <keyword>physical activity;</keyword>
  <keyword>Blood Pressure Monitoring, Ambulatory</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

